Suppr超能文献

内分泌性突眼症中的眼肌抗体。临床及血清学观察。

Eye muscle antibodies in endocrine exophthalmos. Clinical and serological observations.

作者信息

Kahaly G, Moncayo R, Bemetz U, Krause U, Beyer J, Pfeiffer E F

机构信息

Abteilung für Innere Medizin, Endokrinologie und Stoffwechsel, Universität Mainz, Germany.

出版信息

Horm Metab Res. 1989 Mar;21(3):137-41. doi: 10.1055/s-2007-1009173.

Abstract

Serum samples were obtained from 65 patients with endocrine exophthalmos class I-V. In 33/65 patients who were treated either with prednisone or with ciclosporin, blood was sampled before, during and after therapy. Antibodies against eye muscle were determined during the course of immunosuppressive therapy in order to have an objective parameter of the therapeutic effect. To ascertain the specificity of the reaction both eye and abdominal muscles were used as antigens in an ELISA system. Both IgG and IgM antibodies were detected. In 45/65 patients (71%) eye muscle antibodies were positive before starting therapy. Antibodies were mostly detected in patients with active disease. Patients with exophthalmos of recent onset always had IgM antibodies whereas patients with chronic exophthalmos were mostly IgG positive. Patients with relapse showed mostly IgG but also IgG and IgM positivity in 2 cases. In 58% of cases only IgG antibodies were found whereas in 34% both IgG and IgM were detected and in 8% only IgM antibodies. There was no association between antibodies directed against eye muscle and thyroid microsomal and thyroglobulin antibodies or with the state of thyroid function. Furthermore there was no correlation between exophthalmos classes and eye muscle antibody binding activity. The antibody level declined during therapy with prednisone or with ciclosporin but rose again 8-12 weeks after stopping the drug in patients with progressive disease.

摘要

从65例I - V级内分泌性突眼患者中采集血清样本。在33例接受泼尼松或环孢素治疗的患者中,在治疗前、治疗期间和治疗后采集血液。在免疫抑制治疗过程中测定抗眼肌抗体,以便获得治疗效果的客观参数。为确定反应的特异性,在ELISA系统中使用眼肌和腹肌作为抗原。检测到IgG和IgM抗体。在45/65例患者(71%)中,治疗开始前眼肌抗体呈阳性。抗体大多在患有活动性疾病的患者中检测到。近期发病的突眼患者总是有IgM抗体,而慢性突眼患者大多IgG呈阳性。复发患者大多为IgG阳性,但有2例同时出现IgG和IgM阳性。在58%的病例中仅发现IgG抗体,34%的病例同时检测到IgG和IgM,8%的病例仅发现IgM抗体。抗眼肌抗体与甲状腺微粒体和甲状腺球蛋白抗体或甲状腺功能状态之间无关联。此外,突眼分级与眼肌抗体结合活性之间无相关性。在用泼尼松或环孢素治疗期间抗体水平下降,但在病情进展的患者停药8 - 12周后再次升高。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验